TipRanks
Go Ultimate55% OFF

NextCell Pharma AB (NXTCL) Cash flow

NextCell Pharma AB Cash Flow

SE:NXTCL's free cash flow for Q3 2026 was $-11.59M. For the 2026 fiscal year, SE:NXTCL's free cash flow was decreased by $-175.09K and operating cash flow was $-11.41M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowAug 25Aug 24Aug 23Aug 22Aug 21
$ -38.86M$ -37.78M$ -43.83M$ -33.31M$ -25.58M
$ -4.24M$ -83.51K$ -4.10M$ -9.37M$ -5.84M
$ 35.03M$ 34.63M$ 835.66K$ 608.17K$ 148.63M
$ 38.72M$ 46.79M$ 50.03M$ 97.12M$ 139.17M
$ -43.05M$ -37.86M$ -47.92M$ -40.90M$ -26.30M

Currency in SEK

NextCell Pharma AB Cash Flow

-100M-50M050M100M150M200M201720182019202020212022202320242025OperatingInvestingFinancing